EverSource Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$944K Buy
6,777
+864
+15% +$121K 0.03% 400
2025
Q4
$726K Buy
5,913
+1,139
+24% +$138K 0.03% 415
2025
Q3
$530K Sell
4,774
-151
-3% -$17.2K 0.02% 480
2025
Q2
$546K Buy
4,925
+1,194
+32% +$127K 0.02% 420
2025
Q1
$418K Buy
3,731
+1,332
+56% +$137K 0.02% 431
2024
Q4
$222K Buy
2,399
+167
+7% +$15K 0.01% 619
2024
Q3
$187K Sell
2,232
-467
-17% -$35.6K 0.01% 581
2024
Q2
$205K Sell
2,699
-415
-13% -$27.7K 0.01% 549
2024
Q1
$203K Sell
3,114
-181
-5% -$13.9K 0.02% 482
2023
Q4
$267K Buy
3,295
+211
+7% +$16.4K 0.02% 368
2023
Q3
$231K Buy
3,084
+85
+3% +$6.54K 0.02% 365
2023
Q2
$231K Buy
2,999
+14
+0.5% +$1.12K 0.03% 371
2023
Q1
$248K Buy
2,985
+84
+3% +$6.96K 0.03% 339
2022
Q4
$249K Sell
2,901
-586
-17% -$46.4K 0.04% 321
2022
Q3
$215K Buy
3,487
+1,843
+112% +$116K 0.05% 288
2022
Q2
$100K Buy
1,644
+568
+53% +$35.2K 0.03% 376
2022
Q1
$64K Buy
1,076
+27
+3% +$1.73K 0.02% 427
2021
Q4
$76K Buy
+1,049
New +$72.3K 0.02% 349

Other funds holding GILD

EverSource Wealth Advisors's GILD Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Gilead Sciences (GILD) stake by 15% in Q1 2026, buying an estimated $121K and bringing the position to 6,777 shares worth $944K. The position accounts for 0.03% of the portfolio, ranked #400.

EverSource Wealth Advisors first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • EverSource Wealth Advisors held 6,777 shares of Gilead Sciences worth $944K as of Q1 2026.
  • EverSource Wealth Advisors bought 864 Gilead Sciences shares in Q1 2026, an estimated $121K.
  • Gilead Sciences made up 0.03% of EverSource Wealth Advisors's portfolio in Q1 2026, its #400 holding.
  • EverSource Wealth Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.